Philips supports AHA’s CIED infection campaign

2638

CIED infectionRoyal Philips is supporting the American Heart Association’s (AHA’S) effort to generate awareness among cross-disciplinary specialties and improve survival rates from cardiovascular implantable electronic device (CIED) infections.

With the support of Philips, the American Heart Association’s national CIED infection initiative will work with medical professionals across a variety of specialities to prevent and properly treat infections resulting from cardiovascular implantable electronic devices such as pacemakers, implantable cardioverter-defibrillators and cardiac resynchronisation devices.

“CIED infection is a major public health problem with substantial morbidity and mortality,” said Jonathan Piccini, director of Cardiac Electrophysiology section at the Duke Heart Center and the current chair of the AHA Get With The Guidelines AF quality improvement registry. “Despite the tremendous impact of these infections on patients and their loved ones, potential life-saving guideline recommended care is infrequently applied.”

“By supporting the American Heart Association, we have a significant opportunity to improve care for a large group of cardiovascular patients,” said Chris Landon, senior vice president and general manager Image Guided Therapy Devices at Philips. “At Philips, we want to support medical professionals and their efforts to follow guideline-directed care and decrease the complications and negative outcomes that too often follow CIED infections.”


LEAVE A REPLY

Please enter your comment!
Please enter your name here